Gene editing to induce FOXP3 expression in human CD4 <sup>+</sup> T cells leads to a stable regulatory phenotype and functionYuchi Honaker, David J. Rawlings, Elizabeth M. Dam et al.|Science Translational Medicine|2020Cited by 118
Homology-Directed Recombination for Enhanced Engineering of Chimeric Antigen Receptor T CellsMalika Hale, David J. Rawlings, Baeckseung Lee et al.|Molecular Therapy — Methods & Clinical Development|2017Cited by 71
Conversion of T-Effector Cells to Immunosuppressive T-Regulatory-like Cells By CRISPR/Cas9-Mediated Integration of a FOXP3 TransgeneYuchi Honaker, David J. Rawlings, Yufei Xiang et al.|Blood|2018Cited by 4
Enabling Gene-Edited, Regulatory-like, T Cells (edTreg) for Treatment of IPEX and Other Autoimmune DisordersYuchi Honaker, David J. Rawlings, Karen Sommer et al.|Blood|2019Cited by 4
398. Site-Specific Introduction of Chimeric Antigen Receptors to Primary Human T CellsMalika Hale, David J. Rawlings, Alexandra E. Grier et al.|Molecular Therapy|2016Cited by 0